BCL9/BCL9L in hepatocellular carcinoma: will it or Wnt it be the next therapeutic target?

被引：1
|
作者：
Moghe, Akshata [1 ,2 ]
Monga, Satdarshan P. [1 ,2 ,3 ]
机构：
[1] Univ Pittsburgh, Sch Med, Dept Med, Div Gastroenterol Hepatol & Nutr, Pittsburgh, PA 15213 USA
[2] Univ Pittsburgh, Sch Med, Med Ctr, Pittsburgh Liver Res Ctr, 200 Lothrop St,S-422 BST, Pittsburgh, PA 15261 USA
[3] Univ Pittsburgh, Sch Med, Dept Pathol, Div Expt Pathol, Pittsburgh, PA 15260 USA
来源：
HEPATOLOGY INTERNATIONAL | 2020年 / 14卷 / 04期
关键词：
EXPRESSION; BCL9;
D O I：
10.1007/s12072-020-10059-5
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：460 / 462
页数：3
相关论文
共 50 条
  • [31] Wnt/β-Catenin Signalling and Its Cofactor BCL9L Have an Oncogenic Effect in Bladder Cancer Cells
    Kotolloshi, Roland
    Gajda, Mieczyslaw
    Grimm, Marc-Oliver
    Steinbach, Daniel
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (10)
  • [32] SOX7 Suppresses Wnt Signaling by Disrupting -Catenin/BCL9 Interaction
    Fan, Rong
    He, HaiYan
    Yao, Wang
    Zhu, YanFeng
    Zhou, XunJie
    Gui, MingTai
    Lu, Jing
    Xi, Hao
    Deng, ZhongLong
    Fan, Min
    [J]. DNA AND CELL BIOLOGY, 2018, 37 (02) : 126 - 132
  • [33] BCL9L and caspase-2-new guardians against aneuploidy
    Chunduri, Narendra Kumar
    Storchova, Zuzana
    [J]. TRANSLATIONAL CANCER RESEARCH, 2017, 6 : S139 - S142
  • [34] The role of BCL9 genetic variation as a biomarker for hepatitis C-related hepatocellular carcinoma in Egyptian patients
    Abbas, Eman Abd El Razek
    Barakat, Ahmed Barakat
    Hassany, Mohamed
    Youssef, Samar Samir
    [J]. JOURNAL OF GENETIC ENGINEERING AND BIOTECHNOLOGY, 2022, 20 (01)
  • [35] The role of BCL9 genetic variation as a biomarker for hepatitis C-related hepatocellular carcinoma in Egyptian patients
    Eman Abd El Razek Abbas
    Ahmed Barakat Barakat
    Mohamed Hassany
    Samar Samir Youssef
    [J]. Journal of Genetic Engineering and Biotechnology, 20
  • [36] Loss of BCL9/9l suppresses Wnt driven tumourigenesis in models that recapitulate human cancer (vol 10, 723, 2019)
    Gay, David M.
    Ridgway, Rachel A.
    Mueller, Miryam
    Hodder, Michael C.
    Hedley, Ann
    Clark, William
    Leach, Joshua D.
    Jackstadt, Rene
    Nixon, Colin
    Huels, David J.
    Campbell, Andrew D.
    Bird, Thomas G.
    Sansom, Owen J.
    [J]. NATURE COMMUNICATIONS, 2019, 10 (1)
  • [37] Decoding the dynamics of BCL9 triazole stapled peptide
    Gaikwad, Vikram
    Choudhury, Asha Rani
    Chakrabarti, Rajarshi
    [J]. BIOPHYSICAL CHEMISTRY, 2024, 307
  • [38] BCL9 Upregulation in Adrenocortical Carcinoma: A Novel Wnt/β-Catenin Activating Event Driving Adrenocortical Malignancy Invited Commentary
    Doherty, Gerard M.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2018, 226 (06) : 995 - 995
  • [39] LATS2 Suppresses Oncogenic Wnt Signaling by Disrupting β-Catenin/BCL9 Interaction
    Li, Jiong
    Chen, Xiaohong
    Ding, Xiangming
    Cheng, Yingduan
    Zhao, Bin
    Lai, Zhi-chun
    Al Hezaimi, Khalid
    Hakem, Razqallah
    Guan, Kun-liang
    Wang, Cun-Yu
    [J]. CELL REPORTS, 2013, 5 (06): : 1650 - 1663
  • [40] Genomic analysis reveals a role for BCL9L in aneuploidy tolerance in colorectal cancer
    Lopez-Garcia, Carlos
    McGranahan, Nicholas
    Hobor, Sebastjian
    Birkbak, Nicolai
    Domingo, Enric
    Rowan, Andrew
    Tomlinson, Ian
    Swanton, Charles
    [J]. CANCER RESEARCH, 2016, 76
12345